Matches in Wikidata for { <http://www.wikidata.org/entity/Q63338570> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q63338570 description "clinical trial" @default.
- Q63338570 description "ensayu clínicu" @default.
- Q63338570 description "klinisch onderzoek" @default.
- Q63338570 description "клінічне випробування" @default.
- Q63338570 name "FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)" @default.
- Q63338570 type Item @default.
- Q63338570 label "FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)" @default.
- Q63338570 prefLabel "FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)" @default.
- Q63338570 P1132 Q63338570-9989BAA3-B3FB-4B25-9BFC-A332010C38DA @default.
- Q63338570 P1476 Q63338570-1062F880-1E0E-4A05-B7F1-E4A8D1D5E337 @default.
- Q63338570 P17 Q63338570-52D3FD55-A957-4A1D-B8B1-54B673B0A6C1 @default.
- Q63338570 P1813 Q63338570-2D50242B-9CB1-4389-A5C7-47BFA7D0FDCF @default.
- Q63338570 P2899 Q63338570-C65CD158-DC87-4628-8B65-5E7FCA294D31 @default.
- Q63338570 P3098 Q63338570-C70608FD-F026-48A5-8FF2-9219A451A631 @default.
- Q63338570 P31 Q63338570-DCE07591-BFD2-4A62-9F09-54E8E7EBD269 @default.
- Q63338570 P4844 Q63338570-15AFD1DB-743B-4E7A-A3E0-CF1A2EFC80A7 @default.
- Q63338570 P4844 Q63338570-1F60FA2C-E633-4CFC-A3A7-B6C63EFC37F8 @default.
- Q63338570 P4844 Q63338570-2B59A1FC-FF63-4A38-9B5E-DDEFDD2347AF @default.
- Q63338570 P4844 Q63338570-40CECA94-2F10-42BD-8F4C-3E53122B0344 @default.
- Q63338570 P580 Q63338570-1CD9E0DC-2F6D-42D3-ABD9-3986D2056DC6 @default.
- Q63338570 P582 Q63338570-98B2819B-1D38-4133-9D1C-685C3C1E997C @default.
- Q63338570 P6099 Q63338570-8B156289-B39D-4BB0-92A0-426B3CE7A7AF @default.
- Q63338570 P6153 Q63338570-A826F1D2-3C9A-4809-957C-0832A3069DAB @default.
- Q63338570 P8363 Q63338570-5EBC93DD-9A5F-49F3-8E88-42157741305E @default.
- Q63338570 P859 Q63338570-1BC2C1A9-D6A4-4A7E-94DA-4C243206A5D3 @default.
- Q63338570 P1132 "+93" @default.
- Q63338570 P1476 "An Open-label 2:1 Randomized Phase II Study of Panitumumab Plus FOLFOXIRI or FOLFOXIRI Alone as First-line Treatment of Patients With Non-resectable Metastatic Colorectal Cancer and RAS Wild Type" @default.
- Q63338570 P17 Q183 @default.
- Q63338570 P1813 "VOLFI" @default.
- Q63338570 P2899 "+18" @default.
- Q63338570 P3098 "NCT01328171" @default.
- Q63338570 P31 Q30612 @default.
- Q63338570 P4844 Q127060 @default.
- Q63338570 P4844 Q183206 @default.
- Q63338570 P4844 Q412197 @default.
- Q63338570 P4844 Q422327 @default.
- Q63338570 P580 "2011-04-01T00:00:00Z" @default.
- Q63338570 P582 "2017-06-01T00:00:00Z" @default.
- Q63338570 P6099 Q42824440 @default.
- Q63338570 P6153 Q1774589 @default.
- Q63338570 P8363 Q78089383 @default.
- Q63338570 P859 Q30268699 @default.